Profile
Dirk Haasner is the founder of 4-Antibody AG.
Formerly, VP-Regulatory, Medical Affairs & Policy at Lundbeck USA Inc. from 2002 to 2015.
Senior Vice President-Global Regulatory Affairs at Ovid Therapeutics, Inc. from 2015 to 2022.
Education includes a graduate degree from the University of Basel, conferred in 1991, and a doctorate from the Basel Institute for Immunology, conferred in 1994.
Former positions of Dirk Haasner
| Companies | Position | End |
|---|---|---|
| OVID THERAPEUTICS INC. | General Counsel | - |
Lundbeck USA Inc. | General Counsel | 01/11/2015 |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Founder | - |
Training of Dirk Haasner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Ovid Therapeutics, Inc.
Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Basel Institute for Immunology
Basel Institute for Immunology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck USA Inc. |
- Stock Market
- Insiders
- Dirk Haasner
















